Multi-morbidity presents an increasing challenge in the global ageing population. Prediction of how and when it will develop is necessary to deliver effective healthcare. The Centre for Evidence-Based Medicine and Academic Health Science Network in Oxford have collated the present body of evidence on biomarkers and multi-morbidity currently published.
This workshop lead by Professors Carl Heneghan and Gary Ford will present key findings in the four areas, serum, molecular, physiological and brain function for interrogation by workshop participants.
The aim of this workshop is to build consensus of how we develop universal definitions of multi-morbidity, to better understand our risk factors and inform healthcare and medical policy.